Finance Contributor

Articles by Tomisin Sanya

12 articles

← Back to profile

Caricature of Phillip Frost, chairman and CEO of OPKO Health, and Bryan Vaughn, president of Diagnostics at Labcorp

News

Labcorp ties $150m of OPKO payout to a revealing $25m test

OPKO’s 4Kscore earnout math hinges on a threshold it won’t disclose

Tomisin SanyaOct 17, 2026

Caricature of Christopher Boerner, board chair and CEO of Bristol Myers Squibb

News

Bristol Myers wins its lung drug trial and the stock falls

Bristol Myers’ lung drug wins its trial, but the stock still fell

Tomisin SanyaOct 14, 2026

News

Medicare’s $12.7bn star bonus pot heads to the courtroom

Medicare Advantage 2027 star ratings face lawsuits worth billions

Tomisin SanyaOct 12, 2026

Caricature of Mark Snyder, chief legal officer of Halozyme, blocking a Keytruda SC syringe at a European border

News

Dutch court shuts Keytruda SC out of eight more markets

Nine EU markets block Keytruda SC as Merck’s 2028 cliff looms

Tomisin SanyaOct 8, 2026

News

Coastal Financial sheds 16% over a $447m Bluevine exit

Analysts call the 16% slide an overreaction to the Bluevine deal.

Tomisin SanyaSep 29, 2026

Caricature of Brett P. Monia, chief executive officer of Ionis Pharmaceuticals, and Levi Garraway, chief medical officer of Roche

News

Ionis stock eyes royalties up to 20% on Roche drug win

Ionis stands to earn up to $400M after Roche’s kidney drug clears Phase 3.

Tomisin SanyaSep 24, 2026

Caricature of Mike Doustdar, chief executive officer of Novo, presenting 2030 ambitions at the company's Capital Markets Day in London

News

Novo Nordisk stock falls as 2026 plan targets peer growth

Novo’s CagriSema beat a low dose of Lilly’s tirzepatide on 21 September, but investors sold on 2030 ambitions that pitch the drugmaker as an ordinary-growth pharma

Tomisin SanyaSep 22, 2026

Caricature illustration of Medtronic's Hugo robotic-assisted surgery system with the LigaSure RAS Maryland instrument

News

FDA clears Medtronic’s vessel sealer for the Hugo robot

Medtronic’s robotic platform now has its vessel-sealing tool in the US, but the procedures it can actually perform there haven’t changed yet.

Tomisin SanyaSep 18, 2026

News

Buffett seals the end of an era at Berkshire

Buffett completed a 61-year transition that puts the trillion-dollar conglomerate fully into the hands of its next generation.

Tomisin SanyaSep 18, 2026

Caricature illustration of a Johnson & Johnson executive handing a heart implant to a jaguar, representing the sale of the Laminar program to Jaguar LAA

News

J&J offloads $400M Laminar bet and exits LAA closure

J&J sold its $400 million Laminar program, narrowing competition for Boston Scientific and Abbott in LAA closure.

Tomisin SanyaSep 17, 2026

News

Beta Bionics cuts 2026 forecast by $10m after Mint nod

Beta Bionics could shift up to $10M to 2027 as customers await its new patch pump.

Tomisin SanyaSep 15, 2026

Credit & Loans

The SBA Loan Program Most Small Business Owners Overlook

The 7(a) loan gets the headlines and the consultant pitches, but a smaller SBA program quietly funds tens of thousands of the borrowers traditional banks turn down.

Tomisin SanyaJun 3, 2026